Specificity protein 1 (SP1) (SP1)

Specificity protein 1 (SP1) is a ubiquitous zinc-finger transcription factor that regulates the expression of thousands of genes involved in cell growth, survival, and differentiation (UniProt P08047). It binds to GC-rich motifs in gene promoters, facilitating the recruitment of the transcription machinery to drive the expression of critical factors like VEGF, TGF-beta, and various cell cycle regulators (PubMed: 23563494). In many pathological states, particularly oncology, SP1 is frequently overexpressed and serves as a driver of tumor progression, angiogenesis, and chemoresistance (PubMed: 30107119). Targeting SP1 at the mRNA level using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) has emerged as a strategy to reduce its protein levels and inhibit downstream oncogenic signaling (PubMed: 15622166). Additionally, small molecules like Mithramycin A (Plicamycin) can indirectly target SP1 by binding to the GC-rich DNA sequences, thereby preventing SP1 from initiating transcription (PubMed: 21854446). Despite its therapeutic potential, the broad role of SP1 in maintaining normal cellular homeostasis presents significant challenges regarding systemic toxicity and off-target effects.

Other names

Transcription factor Sp1TSFP1Sp1 transcription factor

Inhibition of DNA binding at GC-rich promoter regions, induction of proteasomal degradation of the SP1 protein, or post-transcriptional gene silencing via RNA interference (siRNA/ASO).